Adverse effects of treatment (Max. 2 points) | Digestive effects: gastritis, ulcer, intestinal alteration, liver disease... Neurological effects (drowsiness, altered consciousness ...) Immunosuppressive effects Cardiovascular effects: hypertension, hypotension, rhythm disturbance, thrombosis. Respiratory effects: irritation of the upper tract, bronchitis, pulmonary edema, pleurisy ... Kidney effects: kidney failure, lithiasis, nephritis ... Others: vertigo, tinnitus, visual disturbances | Mild ≤ 1 effects | 0.5 | |
Moderate = 2 o 3 effects | 1 | |||
Severe > 3 effects | 2 | |||
Associated pathologies (max 2 points) * Only those pathologies that modify the course or prognosis of the neuropathic pain under evaluation are evaluated. |
| |||
Traumatological | Yes | No | Mild = 1 associated pathology | 0 |
Cardiological | Yes | No | ||
Dermatological: important skin lesions (large scars for example) | Yes | No | Moderate = 2 associated pathologies | 1 |
Vascular: arteriovenous or lymphatic lesions | Yes | No | ||
Digestive: pathologies that interfere with the treatment | Yes | No | Severe = 3 or 4 associated pathologies | 1.5 |
Psychiatric: conditions that coexist or interfere with the treatment | Yes | No | ||
Autonomic nervous system disorders | Yes | No | Very severe: 5 or more associated pathologies | 2 |